Literature DB >> 23650116

A pharmacokinetic standard for babies and adults.

Nick Holford1, Young-A Heo, Brian Anderson.   

Abstract

The pharmacokinetic behavior of medicines used in humans follows largely predictable patterns across the human age range from premature babies to elderly adults. Most of the differences associated with age are in fact due to differences in size. Additional considerations are required to describe the processes of maturation of clearance processes and postnatal changes in body composition. Application of standard approaches to reporting pharmacokinetic parameters is essential for comparative human pharmacokinetic studies from babies to adults. A standardized comparison of pharmacokinetic parameters obtained in children and adults is shown for 46 drugs. Appropriate size scaling shows that children (over 2 years old) are similar to adults. Maturation changes are generally completed within the first 2 years of postnatal life; consequently babies may be considered as immature children, whereas children are just small adults.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  adults; allometric scaling; clearance; clinical pharmacokinetics; glomerular filtration; maturation; pediatric; premature babies; renal clearance; standard

Mesh:

Year:  2013        PMID: 23650116     DOI: 10.1002/jps.23574

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  125 in total

1.  Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.

Authors:  Christelle Rodrigues; Catherine Chiron; Elisabeth Rey; Olivier Dulac; Emmanuelle Comets; Gérard Pons; Vincent Jullien
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

2.  Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children.

Authors:  Céline Thibault; Jean Lavigne; Catherine Litalien; Nastya Kassir; Yves Théorêt; Julie Autmizguine
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients.

Authors:  Ling Xue; Wen-Juan Zhang; Ji-Xin Tian; Lin-Na Liu; Hai-Hong Yan; Wen-Wen Zhang; Xiao-Liang Ding; Jing-Jing Zhang; Li-Yan Miao
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.200

4.  Why standards are useful for predicting doses.

Authors:  Nick H G Holford; Brian J Anderson
Journal:  Br J Clin Pharmacol       Date:  2017-02-02       Impact factor: 4.335

5.  Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics.

Authors:  Cécile Ollivier; Andrew Thomson; Efthymios Manolis; Kevin Blake; Kristin E Karlsson; Catherijne A J Knibbe; Gérard Pons; Robert Hemmings
Journal:  Br J Clin Pharmacol       Date:  2019-02-28       Impact factor: 4.335

6.  Comment on "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials".

Authors:  Joseph F Standing; Brian J Anderson; Stefanie Hennig; Nick H Holford; Trevor N Johnston; Catherijne A J Knibbe; Dagan O Lonsdale; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

7.  Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.

Authors:  Yasuhiro Tsuji; Nicholas H G Holford; Hidefumi Kasai; Chika Ogami; Young-A Heo; Yoshitsugu Higashi; Akiko Mizoguchi; Hideto To; Yoshihiro Yamamoto
Journal:  Br J Clin Pharmacol       Date:  2017-03-31       Impact factor: 4.335

8.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

9.  Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.

Authors:  Wei-Wei Lin; Xi-Wen Li; Zheng Jiao; Jin Zhang; Xin Rao; Da-Yong Zeng; Xin-Hua Lin; Chang-Lian Wang
Journal:  Eur J Clin Pharmacol       Date:  2018-11-19       Impact factor: 2.953

10.  Evaluation of a System-Specific Function To Describe the Pharmacokinetics of Benzylpenicillin in Term Neonates Undergoing Moderate Hypothermia.

Authors:  Yuma A Bijleveld; Timo R de Haan; Johanna H van der Lee; Floris Groenendaal; Peter H Dijk; Arno van Heijst; Rogier C J de Jonge; Koen P Dijkman; Henrica L M van Straaten; Monique Rijken; Inge A Zonnenberg; Filip Cools; Alexandra Zecic; Debbie H G M Nuytemans; Anton H van Kaam; Ron A A Mathôt
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.